Fundamental Analysis of TREVENA INC(NASDAQ:TRVN) stock

Fundamental Rating

TRVN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 588 industry peers in the Biotechnology industry. TRVN may be in some trouble as it scores bad on both profitability and health. TRVN is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year TRVN has reported negative net income.

In the past year TRVN has reported a negative cash flow from operations.

In the past 5 years TRVN always reported negative net income.

In the past 5 years TRVN always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -157.74%, TRVN is not doing good in the industry: 86.99% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-157.74%
ROE	N/A
ROIC	N/A

ROA(3y)-91.28%

ROA(5y)-69.95%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TRVN has a better Gross Margin (67.48%) than 82.88% of its industry peers.

In the last couple of years the Gross Margin of TRVN has declined.

TRVN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	67.48%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-20.92%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TRVN does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for TRVN has been increased compared to 1 year ago.

The number of shares outstanding for TRVN has been increased compared to 5 years ago.

Compared to 1 year ago, TRVN has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -24.13, we must say that TRVN is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of TRVN (-24.13) is worse than 88.01% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-24.13

ROIC/WACCN/A

WACC4.48%

2.3 Liquidity

TRVN has a Current Ratio of 4.66. This indicates that TRVN is financially healthy and has no problem in meeting its short term obligations.

TRVN has a Current ratio of 4.66. This is comparable to the rest of the industry: TRVN outperforms 51.54% of its industry peers.

A Quick Ratio of 4.66 indicates that TRVN has no problem at all paying its short term obligations.

TRVN has a Quick ratio (4.66) which is in line with its industry peers.

		Industry Rank	Sector Rank
Current Ratio	4.66
Quick Ratio	4.66

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

TRVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.51%, which is quite impressive.

The Revenue has grown by 1608.33% in the past year. This is a very strong growth!

TRVN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.42% yearly.

EPS 1Y (TTM)59.51%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-45.21%

Revenue 1Y (TTM)1608.33%

Revenue growth 3Y0.59%

Revenue growth 5Y-11.42%

Revenue growth Q2QN/A

3.2 Future

TRVN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.93% yearly.

TRVN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 198.34% yearly.

EPS Next Y43.95%

EPS Next 2Y24.84%

EPS Next 3Y17.1%

EPS Next 5Y49.93%

Revenue Next Year-100%

Revenue Next 2Y63.52%

Revenue Next 3Y-25.99%

Revenue Next 5Y198.34%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TRVN. In the last year negative earnings were reported.

Also next year TRVN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

TRVN's earnings are expected to grow with 17.10% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y24.84%

EPS Next 3Y17.1%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for TRVN!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

TREVENA INC

NASDAQ:TRVN (4/25/2024, 4:35:28 PM)

0.41

+0.03 (+7.61%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap7.51M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-157.74%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	67.48%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.16

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	4.66
Quick Ratio	4.66
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)59.51%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y43.95%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)1608.33%

Revenue growth 3Y0.59%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

TREVENA INC (TRVN)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens